NASDAQ:AERI
Delisted
Aerie Pharmaceuticals Stock News
$15.25
+0 (+0%)
At Close: Feb 17, 2023
Aerie Pharmaceuticals (AERI) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Thursday, 04'th Aug 2022
Aerie (AERI) delivered earnings and revenue surprises of 38.46% and 2.59%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development and commercialization of first-in-class ophthalmic therapies,
Aerie (AERI) Starts Late-Stage Study to Treat Dry Eye Disease
04:03pm, Wednesday, 25'th May 2022
Aerie Pharmaceutials (AERI) doses the first patient in a phase III study on its investigational TRMP8 agonist drug for the treatment of dry eye disease.
Aerie Pharmaceuticals' (AERI) CEO Raj Kannan on Q1 2022 Results - Earnings Call Transcript
03:48am, Saturday, 07'th May 2022
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Hans Vitzthum – LifeSci Partners Raj Kannan – Chief Executive Officer Gary S
Aerie (AERI) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
05:18pm, Friday, 06'th May 2022
Aerie (AERI) misses on both earnings and revenues for the first quarter of 2022.
Aerie Pharmaceuticals (AERI) Reports Q1 Loss, Misses Revenue Estimates
07:34pm, Thursday, 05'th May 2022
Aerie (AERI) delivered earnings and revenue surprises of -1.54% and 1.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Aerie (AERI) Expands Market Presence Despite Stiff Competition
04:33pm, Monday, 11'th Apr 2022
Aerie (AERI) is progressing well with the development of its ophthalmology pipeline. Its partnership with Santen Pharmaceuticals allows it to expand the presence of its drugs outside the United States
93 Biggest Movers From Friday
09:25am, Monday, 28'th Feb 2022 Benzinga
Gainers Inspirato Incorporated (NASDAQ: ISPO ) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI ) jumped 45.4% to settle at $0.5979 on Friday. EF Hutton recently initiated coverage on the stock with a Buy rating and a $2 price target. CarGurus, Inc. (NASDAQ: CARG ) shares gained 44% to close at $46.44 after the company reported better-than-expected Q4 results. Farfetch Limited (NYSE: FTCH ) climbed 39.4% to close at $20.92 after the company reported better-than-expected Q4 EPS results. TD Holdings, Inc. (NASDAQ: GLG ) gained 38.9% to settle at $0.25 amid overall market strength as investors react to the ongoing Russia-Ukraine conflict. KAR Auction Services, Inc. (NYSE: KAR ) shares climbed 38.4% to close at $18.94 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2 billion. Guggenheim upgraded KAR Auction Services from Sell to Neutral. Imperial Petroleum Inc. (NASDAQ: IMPP ) gained 33.8% to close at $2.10. Universal Security Instruments, Inc. (NYSE: UUU ) climbed 32.9% to close at $3.96 after the company reported a joint merger deal with Infinite Reality.
Aerie Pharmaceuticals (AERI) Stock: Why It Substantially Increased
03:16pm, Sunday, 27'th Feb 2022
The Aerie Pharmaceuticals Inc (NASDAQ: AERI) stock increased by 29.49% in the most recent trading session. This is why.
45 Stocks Moving In Friday''s Mid-Day Session
05:02pm, Friday, 25'th Feb 2022 Benzinga
Gainers KAR Auction Services, Inc. (NYSE: KAR ) shares climbed 39.2% to $19.05 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2 billion. Guggenheim upgraded KAR Auction Services from Sell to Neutral. CarGurus, Inc. (NASDAQ: CARG ) shares jumped 38% to $44.51 after the company reported better-than-expected Q4 results. Cyren Ltd. (NASDAQ: CYRN ) shares jumped 37.9% to $6.55 after gaining around 119% on Thursday. Cyren regained compliance with Nasdaq listing requirements. Farfetch Limited (NYSE: FTCH ) gained 26.7% to $19.02 after the company reported better-than-expected Q4 EPS results. Universal Security Instruments, Inc. (NYSE: UUU ) jumped 23% to $3.6796 after the company reported a joint merger deal with Infinite Reality. Paramount Group, Inc. (NYSE: PGRE ) gained 22.2% to $11.35. BVK and Paramount Joint Venture acquired M&M''s World Flagship Store at 1600 Broadway for $191.5 million. Aerie Pharmaceuticals, Inc. (NASDAQ: AERI ) surged 21.3% to $7.16 as the company swung to a profit in the fourth quarter.
AERI stock gains as company swings to profits in Q4 (AERI)
03:46pm, Friday, 25'th Feb 2022 Seeking Alpha
Aerie Pharmaceuticals <> is trading sharply higher in morning hours to record the biggest intraday gain since 2017 after the commercial-stage pharma company…
Aerie, Schrodinger top healthcare gainers; while Baudax Bio, The Joint lead losers'' pack
03:01pm, Friday, 25'th Feb 2022 Seeking Alpha
Aerie Pharmaceuticals (AERI) +25%. Schrodinger (SDGR) +17%. Baudax Bio BXRX -55%. The Joint (JYNT) -15%.
Aerie Pharmaceuticals, Inc. (AERI) CEO Raj Kannan on Q4 2021 Results - Earnings Call Transcript
02:48am, Friday, 25'th Feb 2022 Seeking AlphaAerie Pharmaceuticals, Inc. (AERI) CEO Raj Kannan on Q4 2021 Results - Earnings Call Transcript
09:48pm, Thursday, 24'th Feb 2022
Aerie Pharmaceuticals, Inc. (AERI) CEO Raj Kannan on Q4 2021 Results - Earnings Call Transcript
Aerie Pharmaceuticals Non-GAAP EPS of $1.09 beats by $1.77, revenue of $114.7M beats by $83.54M
09:10pm, Thursday, 24'th Feb 2022 Seeking Alpha
Aerie Pharmaceuticals press release (AERI): Q4 Non-GAAP EPS of $1.09 beats by $1.77.Revenue of $114.7M (+364.4% Y/Y) beats by $83.54M.Outlook: Glaucoma franchise net product…